PHM7 Stock Overview
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$45.56 |
| 52 Week High | US$47.30 |
| 52 Week Low | US$36.75 |
| Beta | 0.68 |
| 11 Month Change | -3.46% |
| 3 Month Change | n/a |
| 1 Year Change | 19.33% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 15.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHM7 | BG Tobacco | BG Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 0.2% |
| 1Y | 19.3% | 11.7% | 12.4% |
Return vs Industry: PHM7 exceeded the BG Tobacco industry which returned 11.5% over the past year.
Return vs Market: PHM7 exceeded the BG Market which returned 11.6% over the past year.
Price Volatility
| PHM7 volatility | |
|---|---|
| PHM7 Average Weekly Movement | n/a |
| Tobacco Industry Average Movement | 2.3% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in BG Market | 7.5% |
| 10% least volatile stocks in BG Market | 2.5% |
Stable Share Price: PHM7's share price has been volatile over the past 3 months compared to the BG market.
Volatility Over Time: Insufficient data to determine PHM7's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
| PHM7 fundamental statistics | |
|---|---|
| Market cap | €85.47b |
| Earnings (TTM) | €9.44b |
| Revenue (TTM) | €18.43b |
9.0x
P/E Ratio4.6x
P/S RatioIs PHM7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHM7 income statement (TTM) | |
|---|---|
| Revenue | US$20.04b |
| Cost of Revenue | US$5.81b |
| Gross Profit | US$14.23b |
| Other Expenses | US$3.97b |
| Earnings | US$10.27b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.02 |
| Gross Margin | 71.03% |
| Net Profit Margin | 51.24% |
| Debt/Equity Ratio | -736.0% |
How did PHM7 perform over the long term?
See historical performance and comparison